CURRENT STUDIES

   Upcoming Studies

•  Respiratory Syncytial Virus (RSV) Infection
• Gender: Male and Female
• Adults 18 years of age and older

•  Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Virus-Like Particle (VLP) Vaccine
• Gender: Male and Female
• Adults 60 years of age and older

   Covid-19

•  Age Groups: 18 or older
• Gender: Male and Female
• Duration:  60 Days
• Visits: 18